RevCore for blood clots in leg stents
Part of Heart & circulation clinical trials.
This trial tests a special catheter to remove blood clots that have formed inside a leg vein stent. It may be an option for people who have had a stent in place for more than 6 weeks and have a new clot in certain leg veins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- The stent must have been placed more than 6 weeks ago.
- The clot must be in a large leg vein near the groin, hip, or pelvis (common femoral, external iliac, or common iliac vein).
- The study catheter must be able to reach the clot through your vein.
- You cannot have broken or deformed stent struts, the stent must be fully against the vein wall, and not squeezed too narrow.
- You cannot have clots in both legs at the same time, or certain rare vein birth defects.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different mechanical devices used to remove recent blood clots from the deep veins in your leg (iliac and femoral veins). The goal is to restore blood flow and prevent long-term complications like chronic pain and swelling.
This trial tests a device that removes blood clots from the deep veins of the leg (a condition called deep vein thrombosis or DVT). It aims to see if this procedure helps patients feel better and avoid complications compared to standard care.
This trial is testing a device called ReCana that removes blood clots from veins in the leg or pelvis. It aims to help people whose veins are blocked or narrowed, either for the first time or because a previous stent has become blocked again.
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
This trial tests a new device called the Recana Thrombectomy Catheter to clear blockages in the large veins of the legs or pelvis. It might help people with chronic leg swelling, pain, or open sores caused by poor blood flow out of the leg.
This trial looks at whether taking a blood thinner and an additional clot-prevention medicine (antiplatelet) after iliac vein stenting can improve treatment of certain deep vein clots. It may help prevent the clot from coming back or spreading, but it also increases bleeding risk, so careful eligibility screening is important.
Hear when a new In-stent Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.